Elisa C. Fontana
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 84 publications
Reply to: Prior BRAF Inhibitor Exposure Is Not Enough to Define Resistance in the Phase I Mosperafenib Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 27, 2026
Emerging and Established Targets in Colorectal Cancer: Translating Biology Into Therapeutics.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: April 24, 2026
First-in-Human, Phase I Study of Sigvotatug Vedotin, an Integrin Beta-6-Directed Antibody-Drug Conjugate: Results From Dose Expansion in Advanced Non-Small Cell Lung Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 20, 2026
Phase I Study of Mosperafenib, a Novel Paradox Breaker B-Raf Proto-Oncogene Serine/Threonine Kinase (BRAF) Inhibitor, in Patients With BRAF V600-Mutant Solid Tumors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 27, 2026
Antibody-drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners Foundation.
Journal: ESMO open
Published: March 10, 2026
Early ctDNA Dynamics Predict Response to Mosperafenib in BRAF V600-Mutant Metastatic Colorectal Cancer.
Journal: Cancer research communications
Published: March 10, 2026
Three-Tier Prognostic Stratification of Lung Carcinoids (NET G1-G2-G3) by Multivariable, Data-Driven Integration of Ki-67 and Mitotic Count.
Journal: Endocrine pathology
Published: February 25, 2026
European screening platform for EORTC clinical trials in advanced colorectal cancer 'SPECTAcolor'.
Journal: ESMO gastrointestinal oncology
Published: February 06, 2026
Sovereign AI supercomputers: a global landscape review of unprecedented biomedical research infrastructure.
Journal: Frontiers in artificial intelligence
Published: January 26, 2026
Current landscape, successes, and key challenges in cancer vaccine clinical trials across the UK.
Journal: The Lancet. Oncology
Published: December 25, 2025
First-in-Human, Phase I/II Dose Escalation and Expansion Study of Zelenectide Pevedotin in Patients With Advanced Solid Tumors: Results From Monotherapy Dose Escalation.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 06, 2025
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial.
Journal: Lancet (London, England)
Published: August 29, 2025
Last Updated: 09/26/2026